关于先锋

Company Profile

Pioneer Information

Notice Announcement

Industry News

Environmental information disclosure

Ningxia

Release time:

2023-07-24

Common name Specifications Conversion ratio
Sodium ferulate for injection 0.1g 1
Sodium ferulate for injection 0.3g 1
Anetellithin Tablets 25mg 12
Anetellithin Tablets 25mg 24
Sodium ferulate for injection 0.2g 1
Sodium fructose diphosphate for injection 5g (as anhydrous) 1
Cefoxitin Sodium for Injection 3.0g according to C16H17N307S2 1
Diammonium glycyrrhizinate enteric-coated tablets 50mg 12
Cefoxitin Sodium for Injection 1.0g according to C16H17N3O7S2 1
Ambroxol Hydrochloride Capsules 30mg 24
Guipi Capsule 0.3g per capsule 24
Fenofibrate Capsules 0.2g 20
Clindamycin hydrochloride for injection 0.6g(C18H33C1N205S) 1
Clindamycin hydrochloride for injection 0.3g(C18H33C1N205S) 1
Clindamycin hydrochloride for injection 0.15g (as clindamycin) 1
Azithromycin for Injection 0.5g (500,000 units) 10
Azithromycin for Injection 0.5g (500,000 units) 1
Back →

Related news

2023-03-08

Warmly welcome the entrepreneurs from the 39th class committee of Cheung Kong Graduate School of Business to visit Pioneer Pharmaceutical

Warmly welcome the entrepreneurs from the 39th class committee of Cheung Kong Graduate School of Business to visit Pioneer Pharmaceutical

2023-02-27

Warmly congratulate Pioneer Pharmaceutical Clindamycin Phosphate Injection on obtaining the new approval document, new standard and new Ruijia for generic drug registration!

Warmly congratulate Pioneer Pharmaceutical Clindamycin Phosphate Injection on obtaining the new approval document, new standard and new Ruijia for generic drug registration!

2023-02-25

Warmly congratulate Anhui Pioneer Pharmaceutical Fenofibrate Capsules for being the first to pass the consistency evaluation of generic drugs

Warmly congratulate Anhui Pioneer Pharmaceutical Fenofibrate Capsules for being the first to pass the consistency evaluation of generic drugs